Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 154 (2008), 960-970; DOI  10.1099/mic.0.2007/013805-0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliver, B. G.
Right arrow Articles by White, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliver, B. G.
Right arrow Articles by White, T. C.
Agricola
Right arrow Articles by Oliver, B. G.
Right arrow Articles by White, T. C.
Microbiology 154 (2008), 960-970; DOI  10.1099/mic.0.2007/013805-0
© 2008 Society for General Microbiology

Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi

Brian G. Oliver1,2, Peter M. Silver1,2,{dagger}, Chelsea Marie1,2, Samantha J. Hoot1,2, Sarah E. Leyde2 and Theodore C. White1,2

1 Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA, USA
2 Seattle Biomedical Research Institute, Seattle, WA, USA

Correspondence
Theodore C. WhiteTed.
White{at}sbri.org

The tetracycline (TET) promoter has been used in several systems as an inducible regulator of gene expression. In control analyses, the standard Candida albicans laboratory strain SC5314 was found to have altered susceptibility to a variety of antifungal drugs in the presence of relatively high concentrations (50–200 µg ml–1) of TET. Altered susceptibility was most notable with exposure to amphotericin B (AMB), with a 32-fold increase in susceptibility, and terbinafine (TRB), with a 32-fold decrease in susceptibility. The TET/AMB synergy was observed in several clinical isolates of C. albicans and in the distantly related species Aspergillus fumigatus and Cryptococcus neoformans. The TET/AMB synergy is not related to efflux pump activity, as determined by FACS analyses and by analysis of a strain containing efflux pump deletions. Gene expression analyses by luciferase and by quantitative real-time reverse transcriptase PCR failed to identify significant alterations in expression of any genes associated with resistance. C. albicans grown with TET for 48 h does show a reduction in total cellular ergosterol. Analysis of growth curves suggests that the TET effect is associated with lack of a diauxic shift, which is related to a loss of mitochondrial function. MitoTracker fluorescent dye was used to demonstrate that TET has a direct effect on mitochondrial function. These results demonstrate the need for careful analysis of TET effects when using a TET-inducible promoter, especially in studies that involve antifungal drugs. This study defines some limits to the use of the TET-inducible promoter, and identifies effects on cells that are the result of TET exposure alone, not the result of expression of a targeted gene.


Abbreviations: AMB, amphotericin B; CFW, calcofluor white; CLSI, Clinical Laboratory Standards Institute; CSP, caspofungin; DOX, doxycycline; FLC, fluconazole; ITC, itraconazole; MTR, MitoTracker Red CMXRos; QRT-PCR, quantitative real-time reverse transcription polymerase chain reaction; R123, rhodamine-123; R6G, rhodamine 6G; TET, tetracycline; TRB, terbinafine

{dagger}Present address: North Seattle Community College, Seattle, WA, USA.




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
B. G. Oliver, P. M. Silver, and T. C. White
Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans
J. Antimicrob. Chemother., June 1, 2008; 61(6): 1302 - 1308.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2008 Society for General Microbiology.